Lorenzo Monasta

No ORCID on file · 21 papers in corpus · active 2012-2025

Study types

  • article 8
  • preprint 1

Condition tags

  • endometriosis 8
  • infertility 4
  • chronic_pelvic_pain 1
  • adenomyosis 1
  • dyspareunia 1
article

Background: Diagnosis of endometriosis and evaluation of incidence data are complex tasks because the disease is identified laparoscopically and confirmed histologically. Incidence estimates reported in literature are widely inconsistent, p…

2025
Biomedicines ·doi:10.3390/biomedicines13010095

Background/Objectives: Endometrial cancer (EC) is the second most frequent gynecological malignant tumor in postmenopausal women. Pathogenic mechanisms related to the onset and development of the disease are still unknown. To identify dysre…

2025
International journal of molecular sciences ·doi:10.3390/ijms262311498

Endometrial cancers (ECs) are mainly adenocarcinomas arising from the uterine endometrium. In this work, we employed data-independent acquisition (DIA) mass spectrometry (MS)-based label-free quantification (LFQ-MS) proteomics to analyze th…

preprint 2024
·doi:10.20944/preprints202404.1326.v1

Background: Endometriosis is a female chronic inflammatory disease in which endometrial tissue develops outside the uterine cavity. It is a complex pathology, that significantly contributes to morbidity in premenopausal women, leading to ch…

article 2024
Journal of clinical medicine ·doi:10.3390/jcm13113087

Background/Objectives: Endometriosis is a female chronic inflammatory disease in which endometrial tissue develops outside the uterine cavity. It is a complex pathology, which significantly contributes to morbidity in premenopausal women, l…

2024
International journal of molecular sciences ·doi:10.3390/ijms25094650

Among gynecological cancers, endometrial cancer is the most common in developed countries. Extracellular vesicles (EVs) are cell-derived membrane-surrounded vesicles that contain proteins involved in immune response and apoptosis. A deep pr…

2023
International journal of molecular sciences ·doi:10.3390/ijms242216057

Endometrial cancer (EC) is the most frequent gynecologic cancer in postmenopausal women. Pathogenetic mechanisms that are related to the onset and progression of the disease are largely still unknown. A multi-omics strategy can help identif…

2023
International journal of molecular sciences ·doi:10.3390/ijms241511987

Endometrial cancer (EC) is the most common gynecologic malignancy of the endometrium. This study focuses on EC and normal endometrium phosphoproteome to identify differentially phosphorylated proteins involved in tumorigenic signalling path…

2022
Cancers ·doi:10.3390/cancers14246262

Endometrial cancers (ECs) are mostly adenocarcinomas arising from the inner part of the uterus. The identification of serum biomarkers, either soluble or carried in the exosome, may be useful in making an early diagnosis. We used label-free…

2022
Biomedicines ·doi:10.3390/biomedicines10081857

Endometrial cancer (EC) is the most common gynecologic malignancy, and it arises in the inner part of the uterus. Identification of serum biomarkers is essential for diagnosing the disease at an early stage. In this study, we selected 44 he…

2022
International journal of molecular sciences ·doi:10.3390/ijms23042076

Endometrial cancer (EC) is the most frequent gynaecologic cancer in postmenopausal women. We used 2D-DIGE and mass spectrometry to identify candidate biomarkers in endometrial cancer, analysing the serum protein contents of 10 patients vers…

article 2021
·doi:10.2139/ssrn.3839465
article 2021
International journal of environmental research and public health ·doi:10.3390/ijerph18137175

BACKGROUND: Diagnosis of endometriosis and evaluation of incidence data are complex tasks because the disease is identified laparoscopically and confirmed histologically. Incidence estimates reported in literature are widely inconsistent, p…

2021
Cancers ·doi:10.3390/cancers13143639

Endometrial cancer is the most common gynecologic malignancy arising from the endometrium. Identification of serum biomarkers could be beneficial for its early diagnosis. We have used 2D-Difference In Gel Electrophoresis (2D-DIGE) coupled w…

article 2020
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics10110884

Abnormal uterine bleeding (AUB) is a common symptom in the female population, with an estimated prevalence of 10 to 30% in fertile age and up to 90% in perimenopausal women. In most cases, AUB is due to a benign cause. However, it can also …

article 2020
PloS one ·doi:10.1371/journal.pone.0230828

BACKGROUND: Endometriosis is a debilitating gynecologic disease characterized by the implantation of endometrial tissue in ectopic locations, with signs of severe and chronic inflammation. The new knowledge on endometriosis has highlighted …

2019
Journal of clinical medicine ·doi:10.3390/jcm8050691

Uterine leiomyomas are benign smooth muscle cell tumors originating from the myometrium. In this study we focus on leiomyoma and normal myometrium phosphoproteome, to identify differentially phosphorylated proteins involved in tumorigenic s…

article 2018
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13064

Problem Cytokines have a significant role in the process of embryo implantation, trophoblast growth, and differentiation by modulating the immune and endocrine system. The aim of this study was to investigate the profile of a large set of c…

article 2016
PloS one ·doi:10.1371/journal.pone.0154227

Despite being quite frequent and having serious implications in terms of symptomatology and fertility, data on incidence and prevalence of endometriosis and adenomyosis following gold standard definitions are dramatically lacking. The avera…

2015
Lancet (London, England) ·doi:10.1016/s0140-6736(15)61340-x

BackgroundThe Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable compariso…

2012
Lancet (London, England) ·doi:10.1016/s0140-6736(12)61729-2

BackgroundNon-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the o…